AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 2, 2007). doi:10.1152/ajpheart.00968.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/H220    most recent
00968.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, M.
Right arrow Articles by Yuan, J. X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, M.
Right arrow Articles by Yuan, J. X.-J.
Submitted on August 21, 2007
Accepted on October 30, 2007

Characterization of Agonist-induced Vasoconstriction in Mouse Pulmonary Artery

Minlin Xu1, Oleksandr Platoshyn1, Ayako Makino1, Wolfgang H. Dillmann1, Katerina Akassoglou2, Carmelle V. Remillard1, and Jason X.-J. Yuan3*

1 Department of Medicine, University of California, San Diego, La Jolla, California, United States
2 Department of Pharmacology, University of Califonria, San Diego, La Jolla, California, United States
3 Department of Medicine, University of California-San Diego Medical Center, La Jolla, California, United States

* To whom correspondence should be addressed. E-mail: xiyuan{at}ucsd.edu.

In recent years, transgenic mouse models have been developed to examine the underlying cellular and molecular mechanisms of lung disease and pulmonary vascular disease such as asthma, pulmonary thromboembolic disease, and pulmonary hypertension. However, there has not been systematic characterization of the basic physiological pulmonary vascular reactivity in normal and transgenic mice. This represents an intellectual 'gap' since it is important to characterize basic murine pulmonary vascular reactivity in response to various contractile and relaxant factors to which the pulmonary vasculature is exposed under physiological conditions. The current study evaluates excitation- and pharmacomechanical-contraction coupling in pulmonary arteries (PA) isolated from wild-type Balb c mice. We demonstrate that both pharmaco- and electro-mechanical coupling mechanisms exist in mice PA. These arteries are also reactive to stimulation by {alpha}1-adrenergic agonists, serotonin, endothelin-1, vasopressin, and U46619 (a thromboxane A2 analogue). We conclude that the basic vascular responsiveness of mouse pulmonary arteries is similar to those observed in pulmonary arteries of other species, including rat, pig, and human, albeit on a different scale and to varying amplitudes.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Xu, C. V. Remillard, B. D. Sachs, A. Makino, O. Platoshyn, W. Yao, W. H. Dillmann, K. Akassoglou, and J. X.-J. Yuan
p75 neurotrophin receptor regulates agonist-induced pulmonary vasoconstriction
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1529 - H1538.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.